Protara Therapeutics TARA
NASDAQ TARA
$3.21 -0.04 (-1.23%)
At close: Sep 29, 2026 · 4:00 PM EDT

Protara Therapeutics (TARA) EBITDA Margin (2014)

Updated

Protara Therapeutics (TARA) posted EBITDA Margin of -256.11% for FY2014.

Analysis

Protara Therapeutics (TARA) EBITDA Margin (2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 35.95%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 49.01%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 6.02%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 33.11%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 46.01%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -124.26%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 39.16%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 39.10%
10 Protara Therapeutics 192.02 Mn 192.02 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2014 4.82%
API Access

Protara Therapeutics EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=TARA&period=max&api_key=YOUR_API_KEY